BrightSpring Health Services, Inc. vs FRESENIUS MEDICAL CARE AG, two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where BTSG and FMS diverge most: on debt / equity, BTSG reads 1.09 and FMS reads 0.00; on revenue growth, BTSG reads +38.6% and FMS reads +1.5%. The rest of the comparable metrics sit closer together. What FMS's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | BTSG | FMS |
|---|---|---|
| Price | $59.65 | $25.66 |
| Market cap | $11.8B | $15.0B |
| Sector | Medical Care | Medical Care |
| Stage | Growth | Mature |
| P/E | 36.1 | 14.1 |
| P/B | 5.76 | 0.97 |
| P/S | 0.82 | 0.70 |
| EV/EBITDA | 27.7 | 3.7 |
| Revenue growth | +38.6% | +1.5% |
| Gross margin | 12.7% | — |
| Operating margin | 3.4% | 11.7% |
| Net margin | 2.5% | 6.1% |
| Return on equity | 17.9% | 8.3% |
| Return on assets | 6.1% | 3.8% |
| Return on invested capital | 9.7% | 10.1% |
| FCF yield | 3.4% | 19.4% |
| Dividend yield | — | 1.6% |
| Debt / equity | 1.09 | 0.00 |
| Current ratio | 1.59 | 1.26 |
| Altman Z (solvency) | 4.47 | 1.81 |
| Piotroski F (quality) | 5 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.